Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Tonix Pharm Holdings (TNXP)

Tonix Pharm Holdings (TNXP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Tonix Pharmaceuticals Reports Positive Phase 3 Results for TNX-102 SL in Fibromyalgia, Submits NDA to FDA

Tonix Pharmaceuticals presented Phase 3 RESILIENT study results for TNX-102 SL, showing significant improvements in fibromyalgia symptoms. NDA submitted to FDA.Quiver AI SummaryTonix Pharmaceuticals presented...

TNXP : 0.1330 (+1.45%)
Tonix Pharmaceuticals to Present at the Winter 2024 Investor Summit Virtual

TNXP : 0.1330 (+1.45%)
Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at the American College of Rheumatology (ACR) Convergence 2024 Annual Meeting

TNXP : 0.1330 (+1.45%)
Tonix Pharmaceuticals Announces Poster Presentation at the American College of Rheumatology (ACR) Convergence 2024 Annual Meeting

TNXP : 0.1330 (+1.45%)
Tonix Pharmaceuticals Announces Peer-Reviewed Publication in mSphere Journal Highlighting the Tolerability of Company’s Single-Dose Mpox and Smallpox Vaccine Candidate TNX-801, in Immune-Compromised Animals

TNXP : 0.1330 (+1.45%)
Tonix Pharmaceuticals Reports Third Quarter 2024 Financial Results and Operational Highlights

TNXP : 0.1330 (+1.45%)
Will Trump 2.0 Nurse Biotechs Back To Health: 10 Stocks Retail Is Watching

Less stringent requirements in pharmaceuticals and biotechnology could help biotechs by prompting accelerated drug approvals.

SRNE : 0.0035 (unch)
TNXP : 0.1330 (+1.45%)
IBB : 133.04 (-0.25%)
JAGX : 0.9791 (+1.99%)
NVAX : 7.83 (+6.97%)
INO : 4.07 (-4.57%)
GILD : 88.46 (+0.07%)
MRNA : 39.51 (+7.22%)
VXRT : 0.6100 (+5.15%)
IBIO : 2.18 (-4.39%)
XBI : 91.96 (+0.14%)
PFE : 24.86 (+0.24%)
Tonix Pharmaceuticals Announces Research Agreement with Kenya Medical Research Institute (KEMRI) to Design, Plan and Seek Regulatory Approval for a Phase I Clinical Study of TNX-801 for Mpox in Kenya

TNXP : 0.1330 (+1.45%)
Tonix Pharmaceuticals Presented Data on Potential Mpox Vaccine TNX-801 at World Vaccine Congress-Europe 2024

TNXP : 0.1330 (+1.45%)
Tonix Pharmaceuticals to Present at BIO-Europe® 2024

TNXP : 0.1330 (+1.45%)

Barchart Exclusives

Can Nvidia Stock Rally After Q3 Earnings This Week?
Valued at a market cap of $3.5 trillion, Nvidia is a big tech giant that continues to grow at an enviable pace, even as major earnings beats have become routine. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar